pandayu @pandayu

Recommend Chinese medical innovation assets to help you enter the Chinese market vcbeatglobal.com BeiJing & HongKong Joined May 2009

Tweets

45
Followers

114
Following

486
Likes

0

pandayu @pandayu

4 weeks ago

Surging Experimental Monkey Prices: A Rare & Highly Sought Resource linkedin.com/feed/update/ur…

0 0 1 11 0

View Details

pandayu @pandayu

4 weeks ago

Top 20 Key Medical Robot Enterprises in China linkedin.com/feed/update/ur…

0 0 0 6 0

View Details

pandayu @pandayu

a month ago

🚀 Unlocking the Blueprint for Global Pharma Partnerships: A Look at @AstraZeneca's Strategy in China!

0 0 0 6 0

View Details

pandayu @pandayu

2 months ago

80%+ of China’s TAVR volume. 30%+ CAGR through 2030. And a new front opening in mitral and tricuspid. Structural heart intervention is no longer a Western-only race.

0 0 0 16 0

View Details

pandayu @pandayu

2 months ago

Is Hong Kong reaffirming its position as the ultimate global hub for healthcare capital?

0 0 0 16 0

View Details

pandayu @pandayu

2 months ago

Is the China Biopharma IPO boom a sustainable investment or a recipe for disaster?

0 0 0 8 0

View Details

pandayu @pandayu

2 months ago

The resilient growth of #China's biotech is more than just a trend—it's a story of deep innovation.

0 0 0 10 0

View Details

pandayu @pandayu

2 months ago

Has China become the new center of biopharma outsourcing innovation?

0 0 0 8 0

View Details

pandayu @pandayu

6 months ago

High-end interventions and AI surgical platforms aren't the future. They're 2025's cash-fueled main stage. Here is the financing list for #MedTech companies in 2025：

0 0 0 30 0

View Details

Parkinson's disease market size exceeds $10 billion ,Middle aged and young Parkinson's disease patients account for 5-10% of the total number of Parkinson's disease patients.This is a Chinese Parkinson's Disease Industry Panorama，This map breaks down 6 key tracks:

0 0 0 31 0

View Details

pandayu @pandayu

7 months ago

@vcbeathealth @pfizer @EliLillyandCo @AstraZeneca @sanofi @TakedaOncology @GSK @JNJInnovation @Boehringer 👍

0 0 0 59 0

View Details

pandayu @pandayu

7 months ago

This is a Chinese AI Healthcare Industry Panorama. Who's the Next Global Winner? This map breaks down 4 key tracks:

0 0 0 15 0

View Details

pandayu @pandayu

7 months ago

China's Telemedicine Industry Map Information System Manufacturer

0 0 0 15 0

View Details

pandayu @pandayu

7 months ago

𝐖𝐢𝐥𝐥 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦 𝐭𝐞𝐜𝐡 𝐨𝐫 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐞𝐱𝐞𝐜𝐮𝐭𝐢𝐨𝐧 𝐝𝐞𝐟𝐢𝐧𝐞 𝐂𝐡𝐢𝐧𝐚'𝐬 𝐁𝐬𝐀𝐛 𝐠𝐥𝐨𝐛𝐚𝐥 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩?

0 0 0 8 0

View Details

pandayu @pandayu

7 months ago

This comprehensive map of China’s BsAb landscape reveals how upstream innovation, midstream pipeline depth, and downstream multinational interest are converging to position the country as a pivotal player in next-generation therapeutics.

2 0 0 38 0

View Details

pandayu @pandayu

7 months ago

𝟑 𝐬𝐞𝐢𝐬𝐦𝐢𝐜 𝐬𝐡𝐢𝐟𝐭𝐬: 🔸Tetrabody platforms winning multi-target complexity. 🔸Pharma biotechs dominating Phase 3—speed kills. 🔸MNC deal frenzy—$1B+ upfronts now table stakes.

0 0 0 10 0

View Details

pandayu @pandayu

7 months ago

This China CAR-T Industrial Ecosystem map reveals the battle for next-gen supremacy.𝐖𝐢𝐥𝐥 𝐚𝐥𝐥𝐨𝐠𝐞𝐧𝐞𝐢𝐜 𝐩𝐥𝐚𝐭𝐟𝐨𝐫𝐦𝐬 𝐨𝐫 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐧𝐞𝐭𝐰𝐨𝐫𝐤𝐬 𝐮𝐧𝐥𝐨𝐜𝐤 𝐂𝐀𝐑-𝐓'𝐬 𝐭𝐫𝐢𝐥𝐥𝐢𝐨𝐧-𝐝𝐨𝐥𝐥𝐚𝐫 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥?